Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer immunotherapy.

Manfred Schuster1, Andreas Nechansky, Ralf Kircheis

  • 1Apeiron Biologics Forschungs- und Entwicklungs-GmbH, Brunnerstrasse 59, 1230 Vienna, Austria. manfred.schuster@apeiron-biologics.com

Biotechnology Journal
|August 8, 2006
PubMed
Summary

Cancer immunotherapy offers new hope by targeting disseminated tumor cells. This review explores active and passive strategies, including optimized monoclonal antibodies for anti-cancer vaccination, to combat metastatic spread.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2.

International journal of molecular sciences·2026
Same author

Editorial: Community series in the role of toll-like receptors and their related signaling pathways in viral infection and inflammation, volume II.

Frontiers in immunology·2024
Same author

Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0".

International journal of molecular sciences·2024
Same author

In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.

International journal of molecular sciences·2024
Same author

Editorial: The role of toll-like receptors and their related signaling pathways in viral infection and inflammation.

Frontiers in immunology·2024
Same author

The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation.

International journal of molecular sciences·2023

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer remains a leading cause of death, with standard treatments often failing to prevent metastatic spread.
  • Disseminated tumor cells and micro-metastases pose a significant challenge in effective cancer treatment.
  • Cancer immunotherapy presents a promising avenue for eradicating these elusive cancer cells.

Purpose of the Study:

  • To review concurrent advancements in active and passive cancer immunotherapy.
  • To summarize methods for producing optimized monoclonal antibodies for anti-cancer vaccination.
  • To highlight strategies for improving the efficacy of cancer treatment by targeting metastatic disease.

Main Methods:

  • Review of current literature on active and passive cancer immunotherapy strategies.
  • Analysis of therapeutic potential of tumor-specific antibodies and cellular immune mechanisms.
  • Summary of approaches for the production of monoclonal antibodies for anti-cancer vaccination.

Main Results:

  • Active immunotherapy aims to generate a host immune response against cancer via vaccination.
  • Passive immunotherapy utilizes repeated administration of tumor antigen-specific antibodies.
  • Optimized monoclonal antibodies are crucial for enhancing anti-cancer vaccination efficacy.

Conclusions:

  • Targeting disseminated tumor cells via immunotherapy is a critical strategy to improve cancer patient outcomes.
  • Both active and passive immunotherapy approaches, particularly those involving monoclonal antibodies, show significant therapeutic potential.
  • Further research into optimized monoclonal antibody production is essential for advancing cancer vaccines.

Related Experiment Videos